These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 32687846)
1. Synthesis and cytotoxicity of hybrids of 1,3,4- or 1,2,5-oxadiazoles tethered from ursane and lupane core with 1,2,3-triazole. Popov SA; Semenova MD; Baev DS; Frolova TS; Shestopalov MA; Wang C; Qi Z; Shults EE; Turks M Steroids; 2020 Oct; 162():108698. PubMed ID: 32687846 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of cytotoxic urs-12-ene- and 28-norurs-12-ene- type conjugates with amino- and mercapto-1,3,4-oxadiazoles and mercapto-1,2,4-triazoles. Popov SA; Semenova MD; Baev DS; Frolova TS; Shults EE; Wang C; Turks M Steroids; 2020 Jan; 153():108524. PubMed ID: 31622615 [TBL] [Abstract][Full Text] [Related]
3. The synthesis, antifungal and apoptotic effects of triazole-oxadiazoles against Candida species. Çavuşoğlu BK; Yurttaş L; Cantürk Z Eur J Med Chem; 2018 Jan; 144():255-261. PubMed ID: 29274492 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, docking and anticancer activity of azo-linked hybrids of 1,3,4-thia-/oxadiazoles with cyclic imides. Bhatt P; Kumar M; Jha A Mol Divers; 2018 Nov; 22(4):827-840. PubMed ID: 29948580 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and cytotoxicity of bis-1,3,4-oxadiazoles and bis-pyrazoles derived from 1,4-bis[5-thio-4-substituted-1,2,4-triazol-3-yl]-butane and their DNA binding studies. Purohit M; Prasad VV; Mayur CY Arch Pharm (Weinheim); 2011 Apr; 344(4):248-54. PubMed ID: 21469174 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9. Özdemir A; Sever B; Altıntop MD; Temel HE; Atlı Ö; Baysal M; Demirci F Molecules; 2017 Jul; 22(7):. PubMed ID: 28677624 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic profile of glycosyl-triazole linked to 1,2,4-oxadiazole moiety at C-5 through a straight-chain carbon and oxygen atoms. dos Anjos JV; Neves Filho RA; do Nascimento SC; Srivastava RM; de Melo SJ; Sinou D Eur J Med Chem; 2009 Sep; 44(9):3571-6. PubMed ID: 19345445 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis. Melo de Oliveira VN; Flávia do Amaral Moura C; Peixoto ADS; Gonçalves Ferreira VP; Araújo HM; Lapa Montenegro Pimentel LM; Pessoa CDÓ; Nicolete R; Versiani Dos Anjos J; Sharma PP; Rathi B; Pena LJ; Rollin P; Tatibouët A; Nascimento de Oliveira R Eur J Med Chem; 2021 Aug; 220():113472. PubMed ID: 33940463 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of newer 1,3,4-oxadiazole and 1,2,4-triazole based Topsentin analogues as anti-proliferative agent targeting tubulin. Naaz F; Ahmad F; Lone BA; Pokharel YR; Fuloria NK; Fuloria S; Ravichandran M; Pattabhiraman L; Shafi S; Shahar Yar M Bioorg Chem; 2020 Jan; 95():103519. PubMed ID: 31884140 [TBL] [Abstract][Full Text] [Related]
11. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies. Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672 [TBL] [Abstract][Full Text] [Related]
12. Exploring the Synergistic Anticancer Potential of Benzofuran-Oxadiazoles and Triazoles: Improved Ultrasound- and Microwave-Assisted Synthesis, Molecular Docking, Hemolytic, Thrombolytic and Anticancer Evaluation of Furan-Based Molecules. Irfan A; Faiz S; Rasul A; Zafar R; Zahoor AF; Kotwica-Mojzych K; Mojzych M Molecules; 2022 Feb; 27(3):. PubMed ID: 35164286 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of 1H-1,2,3-triazole linked aryl(arylamidomethyl) - dihydrofurocoumarin hybrids and analysis of their cytotoxicity. Lipeeva AV; Pokrovsky MA; Baev DS; Shakirov MM; Bagryanskaya IY; Tolstikova TG; Pokrovsky AG; Shults EE Eur J Med Chem; 2015 Jul; 100():119-28. PubMed ID: 26079088 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and Antiproliferative Evaluation of Novel Hybrids of Dehydroabietic Acid Bearing 1,2,3-Triazole Moiety. Li FY; Huang L; Li Q; Wang X; Ma XL; Jiang CN; Zhou XQ; Duan WG; Lei FH Molecules; 2019 Nov; 24(22):. PubMed ID: 31752282 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of [1,2,4]triazolo[4,3-a]quinoxaline-1,3,4-oxadiazole derivatives as potent antiproliferative agents via a hybrid pharmacophore approach. Kaneko D; Ninomiya M; Yoshikawa R; Ono Y; Sonawane AD; Tanaka K; Nishina A; Koketsu M Bioorg Chem; 2020 Nov; 104():104293. PubMed ID: 33010622 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and antitrypanosomal activity of heteroaryl-based 1,2,4-triazole and 1,3,4-oxadiazole derivatives. Shaykoon MS; Marzouk AA; Soltan OM; Wanas AS; Radwan MM; Gouda AM; Youssif BGM; Abdel-Aziz M Bioorg Chem; 2020 Jul; 100():103933. PubMed ID: 32446119 [TBL] [Abstract][Full Text] [Related]
17. Design, semisynthesis and cytotoxic activity of novel ester derivatives of betulinic acid-1,2,4 oxadiazoles. Challa K; Bhargavi MV; Krupadanam GL J Asian Nat Prod Res; 2016 Dec; 18(12):1158-1168. PubMed ID: 27314626 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity. Zhang S; Luo Y; He LQ; Liu ZJ; Jiang AQ; Yang YH; Zhu HL Bioorg Med Chem; 2013 Jul; 21(13):3723-9. PubMed ID: 23673215 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents. Puthiyapurayil P; Poojary B; Chikkanna C; Buridipad SK Eur J Med Chem; 2012 Jul; 53():203-10. PubMed ID: 22542958 [TBL] [Abstract][Full Text] [Related]
20. Pyrimido[4,5-b]indole derivatives bearing 1,2,4-oxadiazole moiety as MDM2 inhibitor candidates in cancer treatment. Mehri A; Mardanshahi M; Sirous H; Khanahmad H; Rostami M Future Med Chem; 2023 Mar; 15(6):517-532. PubMed ID: 37097083 [No Abstract] [Full Text] [Related] [Next] [New Search]